Skip to main content

01-06-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The ECOG-ACRIN E2108 trial

Seema Khan puts the results of the phase 3 ECOG-ACRIN E2108 trial of locoregional therapy for de novo stage IV breast cancer in context of the two other studies that addressed the same research question (5:38).

Read transcript

Have your say on Medicine Matters

Visit the conference hub

Image Credits